Elevated Adiponectin in Expressed Prostatic Secretion is a Novel Indicator of Inflammatory Prostatitis

Area of Science:

• Urology
• Immunology
• Biochemistry

Background:

• Prostatitis is a prevalent urologic condition with significant quality of life impacts.
• Current understanding of prostatitis pathogenesis, diagnosis, and treatment remains limited.
• Biomarkers are needed for accurate prostatitis diagnosis and sub-classification.

Purpose of the Study:

• To investigate cytokine profiles in expressed prostatic secretions (EPS) for prostatitis biomarkers.
• To evaluate adiponectin as an inflammatory indicator for sub-classifying prostatitis type III.
• To explore the role of adiponectin in the pathogenesis of inflammatory prostatitis.

Main Methods:

• Cytokine antibody arrays and ELISA were employed to measure cytokine levels in EPS.
• Immunohistochemical staining was used to determine cytokine origins.
• Adiponectin's diagnostic value for prostatitis type III sub-classification was assessed.

Main Results:

• Adiponectin levels were significantly elevated in prostatitis type IIIa compared to type IIIb and controls.
• Adiponectin levels in prostatitis type IV correlated with white blood cell counts in EPS.
• Adiponectin demonstrated moderate diagnostic value for sub-classifying prostatitis type III.

Conclusions:

• Adiponectin plays a key role in the pathogenesis of inflammatory prostatitis.
• Adiponectin may serve as a valuable laboratory marker for prostatitis inflammation.
• Further development of adiponectin-based tests could improve prostatitis diagnosis.